(2021). Lower risk of hospitalization for heart failure, kidney disease and death with sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease. Diabetes Obes Metab, 23, 2207-2214. http://doi.org/10.1111/dom.14437.
(2022). Preventing unscheduled hospitalisations from asthma: a retrospective cohort study using routine primary and secondary care data in the UK (The PUSH-Asthma Study)-protocol paper. Bmj Open, 12, e058356. http://doi.org/10.1136/bmjopen-2021-058356.
(2022). Associations between multiple long-term conditions and mortality in diverse ethnic groups. Plos One, 17, e0266418. http://doi.org/10.1371/journal.pone.0266418.